| Trial ID: | L0853 |
| Source ID: | NCT01748396
|
| Associated Drug: |
Calcitriol
|
| Title: |
Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease Stage 3
|
| Interventions: |
DRUG: Calcitriol|DRUG: Calcium Carbonate
|
| Outcome Measures: |
Primary: Percent changes in FGF-23, Comparison of percent changes in FGF-23 from baseline, 8 weeks after administration | Secondary: Percent changes in Ca, Comparison of percent change in Ca from baseline, 8 weeks after administration|Percent changes in P, Comparison of percent change in P from baseline, 8 weeks after administration|Percent changes in iPTH, Comparison of percent change in intact parathyroid hormone from baseline, 8 weeks after administration|Percent changes in 25(OH)D, Comparison of percent change in 25(OH)D from baseline, 8 weeks after administration|Percent changes in 1,25(OH)2D, Comparison of percent change in 1,25(OH)2D from baseline, 8 weeks after administration
|
| Sponsor/Collaborators: |
Sponsor: Seoul National University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-07
|
| Completion Date: |
2013-01
|
| Results First Posted: |
|
| Last Update Posted: |
2013-02-18
|
| Locations: |
Seoul National University Hospital, Seoul, 110-744, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01748396
|
